📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
12
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
47%
💰 Capital Raise
55%
• Critical: only 0.1 months cash remaining
📉 Score Deterioration
50%
• Score rose 47 points recently (worsening)
• Score in HIGH risk zone (65/100)
📜 Warrant Exercise
25%
• Significant warrants: 16% of shares outstanding
💹 Market Data
Market Cap$57.2K
Shares Outstanding571.85M
Float478.99M
Cash$23.7K
Debt$12.46M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest226
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Sep 30, 2022
xbrl
XBRL WARRANT
Aug 31, 2022
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for EDXC
📊 EDXC FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 EDXC Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.